Bala Lab

The BALA lab investigates 'global' molecular changes in the eye that drive glaucoma, a leading cause of blindness in the United States and worldwide, affecting nearly 80 million people. Although often considered an age-related disease, glaucoma also presents in pediatric populations, where it has a strong genetic basis and severe clinical consequences.

By integrating transcriptomic, epigenomic, developmental, and functional analyses of anterior segment tissues with a broader understanding of retinal and optic nerve pathology in the posterior segment, the BALA lab lab aims to develop a holistic view of glaucoma pathogenesis.